HDAC 6/8 inhibitors (Kancera)

N/A

Report date: 2025/03/20 16:08:38
NME

Base Information

Drug NameHDAC 6/8 inhibitors (Kancera)
Drug Alias NameHDAC 6/8 inhibitors (Grünenthal)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 8 inhibitorsHistone deacetylase 6 inhibitors
TargetsHistone deacetylase 8Histone deacetylase 6
Therapy Area/IndicationsNeuralgiaMultiple MyelomaNeuroblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKancera AB
China Registration ClassN/A

Develop Information

Active CompaniesKancera AB
Inactive CompaniesGrunenthal Gmbh
Active IndicationsNeuralgiaMultiple MyelomaNeuroblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A